Lower CoQ10 impairs mitochondrial ATP production in skeletal muscle, which can manifest as fatigue, myalgias and weakness, particularly in patients taking statins that further reduce endogenous CoQ10 levels. This medication is commonly used for High Cholesterol.
Randomized trials and meta-analyses in statin-treated patients have shown that CoQ10 depletion and/or low circulating levels are associated with muscle symptoms, while supplementation has produced mixed but suggestive improvements in statin-associated myalgia and muscle pain severity.
Caso G et al. Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins. Am J Cardiol. 2007;99(10):1409-1412.; Qu H et al. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7(19):e009835.; Parker BA et al. A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy. Atherosclerosis. 2013;231(1):282-287.
Some side effects may be linked to nutrient depletion caused by this medication.
While studies demonstrate statins effectively lower LDL-C and apoB, research suggests they may also reduce CoQ10 levels. This vital antioxidant plays a crucial role in mitochondrial function, and deficiency can impact brain, muscle, kidney, and heart health. CoQ10 supplementation could be a helpful way to mitigate a potential deficiency when taking a statin therapy.
Research has found vitamin E supplementation significantly increased the antioxidative capacity of LDL, which was partially abolished by statin therapy. Supplementation with vitamin E should be considered for its antioxidant and anti-inflammatory properties that may help reduce the oxidation of LDL and help protect against cardiovascular diseases.
Statins can lead to elevated liver enzymes, which may increase the risk of liver damage. Studies suggest that liver injury can be associated with statins and potent antioxidants like NAC with its anti-inflammatory action is associated with improved liver circulation, hepatoprotective, and therapeutic in liver conditions and disease.
Magnesium supplements and statin medications both inhibit the HMG-CoA and have complementary effects to reducing the production of cholesterol. Magnesium has functions that are crucial to cardiovascular and general health as a catalyst to 300 healthy reactions in the body and 100 in the heart. The association between Magnesium supplementation and statins is also able to offer some protection for painful myopathy as a side effect induced by statins, which may also boost patient compliance. According to research, patients who received the statin drug atorvastatin along with a magnesium treatment had significantly increased levels of serum magnesium, HDL (the good cholesterol), as well as significantly decreased levels of total cholesterol, LDL cholesterol, and triglycerides.
Statin therapy can lead to side effects such as statin-associated muscle symptoms (SAMS), rhabdomyolysis myopathy, and myalgia. Research has demonstrated vitamin D is associated with deficient and insufficient status in patients taking statin drug therapy. It has also found vitamin D to be successful in preventing muscle-related side effects like SAMS. Supplementation with vitamin D should be considered to avoid a potential deficiency and to help protect against muscle related side effects.
Statins can lead to elevated liver enzymes, which may increase the risk of liver damage. Studies suggest that liver injury can be associated with statins and potent antioxidants like alpha lipoic acid with its anti-inflammatory action is associated with improved liver circulation, hepatoprotective, and therapeutic in liver conditions and disease.